Literature DB >> 204625

Antibody and cell-mediated immunity to herpes simplex virus in psychotic depression.

R Cappel, F Gregoire, L Thiry, S Sprecher.   

Abstract

The incidence and antibody titers to herpes simplex virus (HSV) were found significantly higher in patients with psychotic depression as compared to normal controls. Furthermore, the cell-mediated immunity (CMI) to HSV in psychotic depression was similar to that observed after acute HSV infection or recurrence. The results suggest therefore an association between HSV infection and psychotic depression.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 204625

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


  7 in total

Review 1.  Future directions for brain, behavior, and the immune system.

Authors:  M Stein
Journal:  Bull N Y Acad Med       Date:  1992-07

Review 2.  Psychoneuroimmunology: potential relevance to chronic orofacial pain.

Authors:  S J Schleifer; J Marbach; S E Keller
Journal:  Anesth Prog       Date:  1990 Mar-Jun

3.  Search for viral nucleic acid sequences in the post mortem brains of patients with schizophrenia and individuals who have committed suicide.

Authors:  G I Carter; G R Taylor; T J Crow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-03       Impact factor: 10.154

Review 4.  Immune system-central nervous system interactions: effect and immunomodulatory consequences of immune system mediators on the brain.

Authors:  P H Black
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

5.  A possible psychoneuroimmunologic basis for recurrent genital herpes simplex.

Authors:  S M Bierman
Journal:  West J Med       Date:  1983-10

Review 6.  Viruses, schizophrenia, and bipolar disorder.

Authors:  R H Yolken; E F Torrey
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

7.  Antibodies to Epstein-Barr virus, herpes simplex type 1, cytomegalovirus and measles virus in psychiatric patients.

Authors:  T Gotlieb-Stematsky; J Zonis; A Arlazoroff; T Mozes; M Sigal; A G Szekely
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.